? Cancer Research Training and Education Coordination (CRTEC) Education and training have been central to the mission of the Abramson Cancer Center (ACC) throughout its existence. The ACC Cancer Research Training and Education Coordination (CRTEC) component coordinates ACC cancer-related education, training, and career activities. In this role, CRTEC integrates these activities across the Penn campus, including the ACC, the Perelman School of Medicine (PSOM), and nine other Penn Schools that have activities with cancer education and training content. A prime focus of CRTEC is to drive and promote cancer education and training activities in the ACC and across the University of Pennsylvania with the goals of delivering cancer-related education to students, trainees, faculty, and other professionals and expanding and diversifying the cancer workforce through targeted education, training, and mentorship.
The Specific Aims of CRTEC are as follows:
Aim 1 : Coordinate cancer education, training, and career development activities across the ACC and Penn;
Aim 2 : Provide cancer research-related education, training, and mentorship to individuals ranging from high school and undergraduate students to cancer professionals, with an emphasis on ensuring a diverse and enduring pipeline of trainees and future cancer researchers;
and Aim 3 : Evaluate the quality and impact of ACC CRTEC activities to improve ACC education/training and to guide new CRTEC developments. CRTEC impacts students, trainees, and professionals with a goal to advance cancer research careers starting with entry-level professional training through faculty and cancer research leadership roles. CRTEC is led by an ACC Associate Director for Education and Training, senior support staff, and an Operations Committee. It interacts with the Programs, Shared Resources, and Community Outreach and Engagement. CRTEC impacts the ACC by (1) coordinating the already diverse, well-established, and extensive cancer-related education and training activities at the ACC and Penn; (2) improving access to cancer-related education for students, trainees, staff, and professionals; (3) sustaining cancer career development through integrated cancer-related training and mentoring for faculty, trainees, and staff; and (4) enhancing diversity at all levels of education and training. CRTEC leverages formidable strengths at ACC and Penn in cancer education and training that include a compact, accessible, and highly integrated campus with extraordinary depth in all disciplines relevant to cancer research; longstanding cancer-focused education in the ACC, PSOM and other Schools; a uniquely large and diverse portfolio of GME and biomedical postdoctoral training programs, many with decades of NCI and other funding; extensive ACC-directed professional education; and expertise and national leadership in basic, translational, clinical, and population-based cancer research. CRTEC provides ACC members with a central point of contact for innovations in cancer-related education and training.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016520-45
Application #
10088741
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-15
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Waxman, Adam J; Clasen, Suparna; Hwang, Wei-Ting et al. (2018) Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA Oncol 4:e174519
Han, Joseph; Lachance, Catherine; Ricketts, M Daniel et al. (2018) The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate. J Biol Chem 293:4498-4509
Reshef, Ran; Ganetsky, Alex; Acosta, Edward P et al. (2018) Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial. Biol Blood Marrow Transplant :
Gangadhar, Tara C; Savitch, Samantha L; Yee, Stephanie S et al. (2018) Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma. Pigment Cell Melanoma Res 31:73-81
Rosenfeld, Aaron M; Meng, Wenzhao; Luning Prak, Eline T et al. (2018) ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data. Front Immunol 9:2107
Lang, Fengchao; Sun, Zhiguo; Pei, Yonggang et al. (2018) Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy. PLoS Pathog 14:e1007253
Buljan, Vlado A; Graeber, Manuel B; Holsinger, R M Damian et al. (2018) Calcium-axonemal microtubuli interactions underlie mechanism(s) of primary cilia morphological changes. J Biol Phys 44:53-80
Kushner, Carolyn J; Hwang, Wei-Ting; Wang, Shiyu et al. (2018) Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer. Breast Cancer Res Treat 170:45-53
Chang, Changgee; Kundu, Suprateek; Long, Qi (2018) Scalable Bayesian variable selection for structured high-dimensional data. Biometrics :
Min, Eun Jeong; Safo, Sandra E; Long, Qi (2018) Penalized Co-Inertia Analysis with Applications to -Omics Data. Bioinformatics :

Showing the most recent 10 out of 1047 publications